Your browser doesn't support javascript.
loading
Report of the use of patient-derived xenograft models in the development of anticancer drugs in Japan.
Tsumura, Ryo; Koga, Yoshikatsu; Hamada, Akinobu; Kuwata, Takeshi; Sasaki, Hiroki; Doi, Toshihiko; Aikawa, Katsuji; Ohashi, Akihiro; Katano, Ikumi; Ikarashi, Yoshinori; Ito, Mamoru; Ochiai, Atsushi.
Afiliación
  • Tsumura R; Division of Developmental Therapeutics, Exploratory Oncology Research & Clinical Trial Center, National Cancer Center, Kashiwa, Japan.
  • Koga Y; Department of Strategic Programs, Exploratory Oncology Research & Clinical Trial Center, National Cancer Center, Kashiwa, Japan.
  • Hamada A; Division of Molecular Pharmacology and Pharmacokinetics, National Cancer Center Research Institute, Tokyo, Japan.
  • Kuwata T; Department of Pathology and Clinical Laboratories, National Cancer Center Hospital East, Kashiwa, Japan.
  • Sasaki H; Department of Translational Oncology, Fundamental Innovative Oncology Core Center, National Cancer Center Research Institute, Tokyo, Japan.
  • Doi T; Department of Experimental Therapeutics, National Cancer Center Hospital East, Kashiwa, Japan.
  • Aikawa K; Seeds Development Support Section, Translational Research Management Division, National Cancer Center Hospital East, Kashiwa, Japan.
  • Ohashi A; Division of Translational Genomics, Exploratory Oncology Research & Clinical Trial Center, National Cancer Center, Kashiwa, Japan.
  • Katano I; Central Institute for Experimental Animals, Kawasaki, Japan.
  • Ikarashi Y; Office of New Drug V, Pharmaceuticals and Medical Devices Agency, Tokyo, Japan.
  • Ito M; Central Institute for Experimental Animals, Kawasaki, Japan.
  • Ochiai A; Exploratory Oncology Research & Clinical Trial Center, National Cancer Center, Kashiwa, Japan.
Cancer Sci ; 111(9): 3386-3394, 2020 Sep.
Article en En | MEDLINE | ID: mdl-32639672

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Ensayos de Selección de Medicamentos Antitumorales / Ensayos Antitumor por Modelo de Xenoinjerto / Antineoplásicos Tipo de estudio: Prognostic_studies Límite: Animals / Humans País/Región como asunto: Asia Idioma: En Revista: Cancer Sci Año: 2020 Tipo del documento: Article País de afiliación: Japón

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Ensayos de Selección de Medicamentos Antitumorales / Ensayos Antitumor por Modelo de Xenoinjerto / Antineoplásicos Tipo de estudio: Prognostic_studies Límite: Animals / Humans País/Región como asunto: Asia Idioma: En Revista: Cancer Sci Año: 2020 Tipo del documento: Article País de afiliación: Japón